We are live on ! Find out more
AI

Alphabet Inc Portfolio holdings

AUM $4.02B
1-Year Est. Return 215.74%
This Fund
S&P 500
This Quarter Est. Return
+31.09%
1 Year Est. Return
+215.74%
3 Year Est. Return
+350.01%
5 Year Est. Return
+242.03%
10 Year Est. Return
+998.87%
AUM
$1.65B
AUM Growth
-$1.67B
Cap. Flow
-$1.84B
Cap. Flow %
-111.07%
Top 10 Hldgs %
93.15%
Holding
26
New
2
Increased
2
Reduced
4
Closed
2

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$132M
2
VIR icon
Vir Biotechnology
VIR
+$22.3M
3
RAPT
RAPT Therapeutics
RAPT
+$19.2M
4
CRWD icon
CrowdStrike
CRWD
+$1.63M

Top Sells

Rank Stock Value
1
UBER icon
Uber
UBER
+$2B
2
FTSV
Forty Seven, Inc. Common Stock
FTSV
+$8.28M
3
QNCX icon
Quince Therapeutics
QNCX
+$3.71M
4
XYZ
Block Inc
XYZ
+$765K
5
ALEC icon
Alector
ALEC
+$367K

Sector Composition

Rank Sector Weight
1 Technology 44.46%
2 Consumer Discretionary 29.25%
3 Healthcare 25.77%
4 Communication Services 0.52%
5 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LYFT icon
1
Lyft
LYFT
$5.39B
$552M 33.37%
12,828,964
– –
JD icon
2
JD.com
JD
$40.8B
$477M 28.87%
13,553,474
– –
DXCM icon
3
DexCom
DXCM
$27.6B
$176M 10.66%
3,222,724
+2,780,896
+629% +$132M
UBER icon
4
Uber
UBER
$134B
$112M 6.8%
3,781,241
-67,357,104
-95% -$2B
RCUS icon
5
Arcus Biosciences
RCUS
$3.57B
$51M 3.08%
5,049,786
– –
DNTH icon
6
Dianthus Therapeutics
DNTH
$5.68B
$50.6M 3.06%
208,696
– –
FTSV
7
DELISTED
Forty Seven, Inc. Common Stock
FTSV
$40.6M 2.45%
1,030,644
-515,322
-33% -$8.28M
WORK
8
DELISTED
Slack Technologies, Inc.
WORK
$29.2M 1.77%
1,299,771
– –
NET icon
9
Cloudflare
NET
$93B
$27.9M 1.68%
1,632,519
– –
RAPT
10
DELISTED
RAPT Therapeutics
RAPT
$23.1M 1.4%
+104,507
New +$19.2M
VIR icon
11
Vir Biotechnology
VIR
$1.47B
$21M 1.27%
+1,666,666
New +$22.3M
FULC icon
12
Fulcrum Therapeutics
FULC
$248M
$11.9M 0.72%
714,285
– –
SPRO icon
13
Spero Therapeutics
SPRO
$68.9M
$10.7M 0.65%
1,112,473
– –
QNCX icon
14
Quince Therapeutics
QNCX
$17.5M
$10.6M 0.64%
946
-615
-39% -$3.71M
AUTL
15
Autolus Therapeutics
AUTL
$386M
$9.23M 0.56%
699,352
– –
SNAP icon
16
Snap
SNAP
$7.32B
$8.55M 0.52%
523,710
– –
CRWD icon
17
CrowdStrike
CRWD
$187B
$8.53M 0.52%
684,080
+124,080
+22% +$1.63M
GRTS
18
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$8.33M 0.5%
929,022
– –
ATER icon
19
Aterian
ATER
$4.35M
$6.22M 0.38%
87,996
– –
IDYA icon
20
IDEAYA Biosciences
IDYA
$3.41B
$5.65M 0.34%
753,187
– –
CLDR
21
DELISTED
Cloudera, Inc.
CLDR
$4.97M 0.3%
427,710
– –
EVLO
22
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$4.31M 0.26%
53,025
– –
ALEC icon
23
Alector
ALEC
$164M
$3.03M 0.18%
175,866
-21,609
-11% -$367K
DBX icon
24
Dropbox
DBX
$6.81B
$233K 0.01%
13,033
– –
SPGI icon
25
S&P Global
SPGI
$126B
– –
-1,297
Closed -$318K
1
2

Similar funds

JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
MAM
Martingale Asset Management Boston, Massachusetts $3.99B AUM 22.65% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
MGP
Metis Global Partners San Diego, California $4.07B AUM 30.82% 1-Year Est. Return

Alphabet Inc's Q4 2019 Portfolio in Review

As of Q4 2019, Alphabet Inc held 26 positions worth $1.65B, down 50% from $3.33B the previous quarter. Its ten largest holdings account for 93% of the portfolio.

Alphabet Inc withdrew a net $1.84B in Q4 2019, closing 2 positions and reducing 4 holdings. Its most notable exit was Block Inc, an estimated $765K position sold in full.

By sector, the portfolio is most concentrated in Technology at 44% of assets, down from 83% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Alphabet Inc opened a new position in Vir Biotechnology worth $21M.

  • Alphabet Inc's largest Q4 2019 buy was Vir Biotechnology: 1,666,666 shares worth $21M.
  • Alphabet Inc added most to DexCom in Q4 2019, an estimated $132M increase.
  • Alphabet Inc's biggest Q4 2019 reduction was Uber, cutting an estimated $2B.
  • Alphabet Inc fully exited Block Inc in Q4 2019, selling an estimated $765K.
  • Alphabet Inc's ten largest holdings make up 93% of its $1.65B portfolio in Q4 2019.
  • Alphabet Inc opened 2 new positions and closed 2 in Q4 2019.
  • Alphabet Inc's portfolio value fell 50% quarter-over-quarter to $1.65B.

Based on Alphabet Inc's 13F filing for Q4 2019, filed 15 Nov 2022.